DR. RONALD GARY PEARL, M.D.
Osteopathic Medicine at Pasteur Dr, Palo Alto, CA
License number
California G38269
Category
Osteopathic Medicine
Type
Anesthesiology
License number
California G38269
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
California G38269
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
300 Pasteur Dr, Palo Alto, CA 94305
Phone
(650) 723-5024
(650) 725-0009 (Fax)
(650) 725-0009 (Fax)
Professional information
Ronald Gary Pearl, Stanford CA
Specialties:
Critical Care Specialist
Address:
300 Pasteur Dr, Stanford, CA 94305
Education:
University of Chicago, Pritzker School of Medicine - Doctor of Medicine
Stanford Hospital & Clinics - Fellowship - Critical Care Medicine
Stanford Hospital & Clinics - Residency - Anesthesiology
Stanford Hospital & Clinics - Residency - Internal Medicine
Stanford Hospital & Clinics - Fellowship - Critical Care Medicine
Stanford Hospital & Clinics - Residency - Anesthesiology
Stanford Hospital & Clinics - Residency - Internal Medicine
Board certifications:
American Board of Anesthesiology Certification in Anesthesiology, American Board of Anesthesiology Sub-certificate in Critical Care Medicine (Anesthesiology), American Board of Internal Medicine Certification in Internal Medicine
Dr. Ronald G Pearl, Stanford CA - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine
Address:
Stanford Office
300 Pasteur Dr, Stanford 94305
(650) 723-4000 (Phone)
UNIVERSITY Stanford Ave, Stanford 94305
300 Pasteur Dr, Stanford 94305
(650) 723-4000 (Phone)
UNIVERSITY Stanford Ave, Stanford 94305
Certifications:
Anesthesiology, 2013, Critical Care Medicine, 1986, Internal Medicine, 1980
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Stanford Office
300 Pasteur Dr, Stanford 94305
UNIVERSITY Stanford Ave, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
300 Pasteur Dr, Stanford 94305
UNIVERSITY Stanford Ave, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1977
Stanford University Hospital
Graduated: 1978
Graduated: 1985
Graduated: 1981
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1977
Stanford University Hospital
Graduated: 1978
Graduated: 1985
Graduated: 1981
Ronald Gary Pearl, Stanford CA
Specialties:
Internal Medicine, Anesthesiology, Critical Care Medicine, General Practice
Work:
Stanford University
300 Pasteur Dr, Stanford, CA 94305 Stanford Hospital and Clinics
300 Pasteur Dr, Palo Alto, CA 94304
300 Pasteur Dr, Stanford, CA 94305 Stanford Hospital and Clinics
300 Pasteur Dr, Palo Alto, CA 94304
Education:
University of Chicago (1977)
Implantable Arterio-Venous Shunt Devices And Methods For Their Use
US Patent:
2005010, May 19, 2005
Filed:
Oct 7, 2004
Appl. No.:
10/961731
Inventors:
John Faul - Stanford CA, US
Toshihiko Nishimura - Menlo Park CA, US
Peter Kao - Palo Alto CA, US
Ronald Pearl - Palo Alto CA, US
Toshihiko Nishimura - Menlo Park CA, US
Peter Kao - Palo Alto CA, US
Ronald Pearl - Palo Alto CA, US
International Classification:
A61M005/00
US Classification:
604008000
Abstract:
A long-term implantable arterio-venous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. The blood flow rate could be controlled either via an open loop or a closed loop control means. The shunt device could also be a self-adjustable shunt device to self-adjust its structure to control the blood flow rate through its lumen. Based on the effects of the shunt device to the respiratory, cardiac and circulatory system, the implantable shunt device could be beneficial as a therapy to patients with problems or conditions related to these systems.
Use Of Antiproliferative Agents In The Treatment And Prevention Of Pulmonary Proliferative Vascular Diseases
US Patent:
2005011, Jun 2, 2005
Filed:
Mar 15, 2004
Appl. No.:
10/801729
Inventors:
Peter Kao - Palo Alto CA, US
Ronald Pearl - Palo Alto CA, US
Toshihiko Nishimura - Menlo Park CA, US
John Faul - Stanford CA, US
Ronald Pearl - Palo Alto CA, US
Toshihiko Nishimura - Menlo Park CA, US
John Faul - Stanford CA, US
International Classification:
A61K031/401, A61K031/366, A61K031/255
US Classification:
514423000, 514460000, 514548000
Abstract:
Methods of treating lung proliferative vascular disorders by administering an antiproliferative agent are provided. A preferred antiproliferative agent is a HMG-CoA reductase inhibitor, preferably simvastatin. Vascular occlusion in the pulmonary arteries of the patient is reduced as a result of the treatment through a reduction in neointimal hyperplasia and medial hypertrophy, and the restoration of normal endothelial cell function. The treatment also results in a reversal of right side cardiac hypertrophy. Lung proliferative vascular disorders that can be treated include primary pulmonary hypertension, secondary pulmonary hypertension, Eisenmenger's syndrome, chronic thromboembolic disease, pulmonary fibrosis, obliterative bronchiolitis, or lymphangioleiomyomatosis. Dosages and pharmaceutical formulations are provided.
Arterio-Venous Shunt Devices
US Patent:
8048016, Nov 1, 2011
Filed:
Feb 12, 2009
Appl. No.:
12/378438
Inventors:
John L. Faul - Stanford CA, US
Toshihiko Nishimura - Menlo Park CA, US
Peter N. Kao - Palo Alto CA, US
Ronald G. Pearl - Palo Alto CA, US
Toshihiko Nishimura - Menlo Park CA, US
Peter N. Kao - Palo Alto CA, US
Ronald G. Pearl - Palo Alto CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Stanford CA
International Classification:
A61M 19/00
US Classification:
604 8, 604264
Abstract:
A long-term implantable arterio-venous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. The blood flow rate could be controlled either via an open loop or a closed loop control means. The shunt device could also be a self-adjustable shunt device to self-adjust its structure to control the blood flow rate through its lumen. Based on the effects of the shunt device to the respiratory, cardiac and circulatory system, the implantable shunt device could be beneficial as a therapy to patients with problems or conditions related to these systems.
Implantable Arteriovenous Shunt Device
US Patent:
2004024, Dec 9, 2004
Filed:
Apr 6, 2004
Appl. No.:
10/820169
Inventors:
John Faul - Stanford CA, US
Toshihiko Nishimura - Menlo Park CA, US
Peter Kao - Palo Alto CA, US
Ronald Pearl - Palo Alto CA, US
Toshihiko Nishimura - Menlo Park CA, US
Peter Kao - Palo Alto CA, US
Ronald Pearl - Palo Alto CA, US
International Classification:
A61F002/06
US Classification:
604/009000, 623/001240
Abstract:
A long-term implantable arteriovenous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a blood flow rate through the shunt device of at least 5 ml/min after the implantation. The blood flow rate could be controlled either via an open loop or a closed loop control means. The shunt device could also be a self-adjustable shunt device to self-adjust its structure to control the blood flow rate through its lumen. Based on the effects of the shunt device to the respiratory, cardiac and circulatory system, the implantable shunt device could be beneficial as a therapy to patients with problems or conditions related to these systems.